DOLL DAVID S

CIK 00012452061 companyPHILADELPHIA, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001245206

Recent Transactions

18 trades

Purchase
Impax Laboratories, LLC
Exercise of stock option
2004-06-07$6.81/sh+30,000→ 32,279 total
Sale
Impax Laboratories, LLC
Sale of common stock
2004-06-07$21.80/sh−14,000→ 2,279 total
Sale
Impax Laboratories, LLC
Sale of common stock
2004-06-07$21.90/sh−16,000→ 16,279 total
Sale
Impax Laboratories, LLC
Sale of common stock
2004-06-07$21.90/sh−16,000→ 16,279 total
Sale
Impax Laboratories, LLC
Sale of common stock
2004-06-07$21.80/sh−14,000→ 2,279 total
Purchase
Impax Laboratories, LLC
Exercise of stock option
2004-06-07$6.81/sh+30,000→ 32,279 total
Purchase
Impax Laboratories, LLC
Option to buy common stock
2004-04-14$23.05/sh+25,000→ 25,000 total
Award
Impax Laboratories, LLC
Option to buy common stock
2004-04-14$23.05/sh+25,000→ 25,000 total
Award
Impax Laboratories, LLC
Option to buy common stock
2004-04-14$23.05/sh+25,000→ 25,000 total
Purchase
Impax Laboratories, LLC
Option to buy common stock
2004-04-14$23.05/sh+25,000→ 25,000 total
Award
Impax Laboratories, LLC
Option to buy common stock
2003-03-10$3.04/sh+30,000→ 30,000 total
Award
Impax Laboratories, LLC
Option to buy common stock
2003-03-10$3.04/sh+30,000→ 30,000 total
Award
Impax Laboratories, LLC
Option to buy common stock
2002-03-08$6.72/sh+30,000→ 30,000 total
Award
Impax Laboratories, LLC
Option to buy common stock
2002-03-08$6.72/sh+30,000→ 30,000 total
Award
Impax Laboratories, LLC
Option to buy common stock
2001-09-24$11.11/sh+40,000→ 40,000 total
Award
Impax Laboratories, LLC
Option to buy common stock
2001-09-24$11.11/sh+40,000→ 40,000 total
Award
Impax Laboratories, LLC
Option to buy common stock
2001-01-19$6.81/sh+45,000→ 75,000 total
Award
Impax Laboratories, LLC
Option to buy common stock
2001-01-19$6.81/sh+45,000→ 75,000 total

Companies

Impax Laboratories, LLC
Senior V.P. - Sales/Marketing

Recent Filings

Address

C/O IMPAX LABORATORIES, INC. 3735 CASTOR AVENUE

PHILADELPHIA, PA, 19124

View on SEC.gov